scispace - formally typeset
B

Bernhard Berger

Researcher at University of Tübingen

Publications -  21
Citations -  1492

Bernhard Berger is an academic researcher from University of Tübingen. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 14, co-authored 21 publications receiving 1316 citations.

Papers
More filters
Journal ArticleDOI

Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

TL;DR: In patients with early-stage Hodgkin's lymphoma and a favorable prognosis, treatment with two cycles of ABVD followed by 20 Gy of involved-field radiation therapy is as effective as, and less toxic than, four cycles ofABVD following by 30 Gy ofinvolved- field radiation therapy.
Journal ArticleDOI

High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes

TL;DR: In this paper, a questionnaire was sent to all members of the EORTC Radiation Oncology Group and Head and Neck Group (111 institutions) to evaluate the widespread use of cetuximab and radiotherapy in HNC and to estimate the frequency of grades III and IV skin reactions in the radiation portals associated with this protocol.
Journal ArticleDOI

Radiation Therapy for Gorham-Stout Syndrome: Results of a National Patterns-of-Care Study and Literature Review

TL;DR: RT may prevent disease progression effectively in Gorham-Stout syndrome in 77% to 80% of cases and total doses ranging from 30 to 45 Gy applied after computed tomography-based treatment planning are recommended.
Journal ArticleDOI

External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis

TL;DR: The results of this series have confirmed the efficacy and safety of postoperative RT for diffuse pigmented villonodular synovitis and should be considered for patients with suspected or proven residual disease.
Journal ArticleDOI

Evidence-based radiation oncology: oesophagus.

TL;DR: The available evidence is summarized and the role of radiation-based treatment options for oesophageal cancer is defined to define the role.